Search the Newsreel

LeMaitre Vascular Inc (LMAT) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and ...

LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates

LeMaitre Vascular (LMAT) reported Q2 earnings of $0.74 per share, falling short of the Zacks Consensus Estimate of $0.81, though it was an increase from $0.60 a year ago. The company's revenues of $70.38 million also missed expectations, despite being higher than the $64.23 …

LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2026 Earnings Guidance

LeMaitre Vascular (NASDAQ:LMAT) has lowered its third-quarter 2026 earnings guidance, projecting EPS of $0.660–$0.710 and revenue of $66.3–$68.3 million, both below analyst consensus. The company also updated its full-year 2026 EPS guidance to $2.840–$2.940. Despite the lowered outlook, analyst sentiment remains "Moderate Buy" with …

How Investors Are Reacting To LeMaitre Vascular (LMAT) Slower Projected Revenue Growth And Mixed Earnings Track Record

Earnings call transcript: LeMaitre Vascular slips on Q2 2026 miss, cuts outlook

LeMaitre Vascular reported a Q2 2026 earnings and revenue miss, leading to a significant after-hours stock drop. Despite strong year-over-year growth and margin expansion, the company cut its full-year organic revenue growth outlook due to foreign exchange pressures, Middle East shipping delays, and cardiac …

LeMaitre says Artegraft is now approved in 56 countries

LeMaitre (NASDAQ: LMAT) reported strong Q2 2026 financial results with net sales up 10% year-over-year to $70.4 million and diluted EPS up 23% to $0.74. A key growth driver was Artegraft, whose sales increased by 34%, now representing 21% of total sales and approved …

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 14.61% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (LMAT) is a significant player in the healthcare sector, specifically in medical instruments for vascular surgery, with a market capitalization of $2.37 billion. The company shows strong financial health with 11.20% revenue growth, a 16.55% return on equity, and a forward …

LeMaitre Vascular earnings on deck as margin gains test continues

LeMaitre Vascular is set to announce its second-quarter earnings, with investors closely watching its ability to maintain significant margin expansion and accelerate profit growth. Analysts anticipate earnings of $0.81 per share on revenue of $71.5 million, reflecting substantial year-over-year growth. The company's premium valuation …

LeMaitre Q2 2026 Financial Results

LeMaitre Vascular, Inc. reported strong Q2 2026 financial results with sales up 10% to $70.4 million and EPS up 23% to $0.74, driven by a 34% increase in Artegraft sales and operational efficiencies. The company announced a quarterly dividend of $0.25/share and provided optimistic …

LeMaitre: Q2 Earnings Snapshot

LeMaitre Vascular Inc. (LMAT) reported a second-quarter profit of $17.1 million, or 74 cents per share, on revenue of $70.4 million. The medical device maker anticipates revenue for the current quarter to be between $66.3 million and $68.3 million, with full-year earnings projected at …

Applied Industrial Technologies stock hits all-time high at 352.91 USD

Applied Industrial Technologies (AIT) stock reached an all-time high of $352.91, currently trading at $353.46, reflecting strong market sentiment and fundamentals. The company reported robust Q3 2026 earnings with EPS meeting expectations and revenue surpassing forecasts. Additionally, DA Davidson initiated coverage with a buy …

Are Industrial Products Stocks Lagging Applied Industrial Technologies (AIT) This Year?

This article examines the year-to-date performance of Applied Industrial Technologies (AIT) and Idex (IEX) within the Industrial Products sector. It highlights that AIT has outperformed the sector, gaining 37.1% compared to the sector's 18.4%. Both AIT and IEX hold a Zacks Rank of #2 …

LeMaitre Vascular, Inc. $LMAT Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC reduced its stake in LeMaitre Vascular, Inc. (LMAT) by 34.9% in the first quarter, selling 27,990 shares and retaining 52,252 shares valued at approximately $5.7 million. The medical instruments supplier reported strong Q1 earnings, beating estimates with $0.68 EPS …

LeMaitre (NASDAQ:LMAT) Misses Q2 CY2026 Revenue Estimates, Stock Drops 11.6%

LeMaitre (NASDAQ:LMAT) Misses Q2 CY2026 Revenue Estimates, Stock Drops 11.6% Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street's revenue expectations in Q2 CY2026, but sales rose 9.6% year on year to $70.38 million. Next quarter's revenue guidance of $67.3 million underwhelmed, coming in …

LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results

LeMaitre Vascular (LMAT) Earnings Date and Reports 2026

Guotai Haitong Securities Sets Board Meeting to Review Interim Results and Dividend Plan

Here's Why We Think Khaitan (India) (NSE:KHAITANLTD) Might Deserve Your Attention Today

Edgestream Partners L.P. Reduces Holdings in Applied Industrial Technologies, Inc. $AIT

Edgestream Partners L.P. significantly reduced its stake in Applied Industrial Technologies (NYSE:AIT) by 75.1% in the first quarter, selling over 29,000 shares and retaining a holding valued at approximately $2.6 million. Despite this, institutional investors collectively own 93.52% of AIT. The company recently declared …

Amundi Purchases 107,067 Shares of Applied Industrial Technologies, Inc. $AIT

Amundi increased its stake in Applied Industrial Technologies (AIT) by 157.8% in the first quarter, now holding 174,907 shares valued at $46.4 million. Institutional investors own 93.52% of AIT, and Wall Street analysts maintain a "Moderate Buy" consensus with an average price target of …

Khaitan (India) net profit rises 56% in Q1FY27 on electrical sales

Radico Khaitan Shares Gain 2.01% in Early Trade

LeMaitre (LMAT) Reports Earnings Tomorrow: What To Expect

LeMaitre (LMAT) Reports Earnings Tomorrow: What To Expect Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be announcing earnings results this Tuesday after market close. Here's what you need to know. LeMaitre met analysts' revenue expectations last quarter, reporting revenues of $66.55 million, up 11.2% …

LeMaitre Vascular (LMAT) Holds A 15% Undervalued View, Is The Stock Fully Priced?

LeMaitre Vascular (LMAT) closed at $101.32 on July 29, 2026, and is considered 15% undervalued with a fair value of $118.75 based on analyst forecasts and a strong product pipeline. However, its P/E ratio of 37.1x screens as expensive against the market and industry, …

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Moderate Buy" by Brokerages

LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received an average "Moderate Buy" rating from brokerages, with an average 12-month price target of $112.60. The company recently surpassed quarterly EPS expectations and saw an 11.1% revenue increase. Despite insider stock sales totaling approximately $5.9 million, institutional investors …

Khaitan (India) standalone net profit rises 56.41% in the June 2026 quarter

Precision Trading with Lemaitre Vascular Inc. (LMAT) Risk Zones

This article from Stock Traders Daily provides a detailed analysis of Lemaitre Vascular Inc. (LMAT) focusing on precision trading strategies and risk zones. It highlights near-term strong sentiment, mid-term neutrality, and long-term positive bias, along with specific entry, target, and stop-loss levels for different …

Sei Investments Co. Boosts Stock Holdings in LeMaitre Vascular, Inc. $LMAT

Sei Investments Co. increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 30.7% in the first quarter, now holding 136,674 shares valued at $14.92 million. Other

Brait PLC Revenue Breakdown – JSE:BAT

LeMaitre Vascular Inc (LMAT) Institutional Confidence

LeMaitre Vascular Inc (LMAT) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. This score reflects a quarter-over-quarter increase of 8.41% in institutional shareholding proportion, which currently stands at 102.98%. ETHSX is the largest institutional shareholder, …

Radico Khaitan Ltd gains for fifth session

Bajaj Housing Finance, Radico, Equitas SFB, KPIT Tech, Eris, Vinati Organics And More Q1 Review — Check Motilal Oswal's Latest Ratings, Target Prices, Upside Potential

LeMaitre Vascular Inc (LMAT) Financial Health: Profitability & Balance Sheet Analysis

LeMaitre Vascular Inc (LMAT) has a robust financial status with a current financial score of 9.04, ranking 11th in the Healthcare Equipment & Supplies industry. The company demonstrated high operating efficiency with a 11.16% year-over-year increase in quarterly revenue to $66.55M and a 42.39% …

Applied Industrial Technologies Inc (AIT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Applied Industrial Technologies Inc (AIT), noting its current valuation score of 7.44 within the Machinery, Tools, Heavy Vehicles, Trains & Ships industry. It highlights the company's P/E ratio of 31.19, indicating it is below its recent high …

LeMaitre Vascular (LMAT) insider Bridget Ross files to sell 4,322 shares

LeMaitre Vascular insider Bridget A. Ross has filed to sell 4,322 shares of common stock, valued at $449,241.48, through a Form 144. The sale is expected on July 29, 2026, and relates to a stock option exercise. Ross previously sold 5,044 shares for $560,366.40 …

Radico Khaitan Q1 Results 2027: PAT Jumps 75.9% YoY; Revenue Grows 10.4%